MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

Respiratory

Search medical newsFind research, conditions and clinical updates
  • Home
  • Specialties
  • Respiratory
  • Page 6
Early Biologic Initiation in Severe Asthma: Enhancing Remission and Clinical Outcomes from Global Real-World Cohorts
Posted inClinical Updates news Respiratory

Early Biologic Initiation in Severe Asthma: Enhancing Remission and Clinical Outcomes from Global Real-World Cohorts

Posted by By MedXY 09/16/2026
Earlier initiation of biologic therapies in severe asthma improves clinical remission rates, reduces exacerbations, preserves lung function, and decreases corticosteroid dependence, supporting a shift from reserving to preserving treatment paradigms.
Read More
Extracorporeal Membrane Oxygenation without Mechanical Ventilation in ARDS: Insights from an International Cohort Study
Posted inCritical Care news Respiratory

Extracorporeal Membrane Oxygenation without Mechanical Ventilation in ARDS: Insights from an International Cohort Study

Posted by By MedXY 09/16/2026
This study evaluates ECMO as a standalone respiratory support in ARDS patients avoiding invasive mechanical ventilation, highlighting outcomes, strategy failures, and mortality implications.
Read More
From Mild-to-Moderate to Severe Asthma: Risk Factors and Patient Profiles from the NORDSTAR Cohort and Advances in Severe Asthma Management
Posted inClinical Updates news Respiratory

From Mild-to-Moderate to Severe Asthma: Risk Factors and Patient Profiles from the NORDSTAR Cohort and Advances in Severe Asthma Management

Posted by By MedXY 09/16/2026
This review summarizes the progression risk from mild-to-moderate to severe asthma based on the NORDSTAR cohort and integrates emerging evidence on biologic therapies that improve severe asthma outcomes across diverse patient profiles.
Read More
Distinct Lipid Metabolic Profiles Unveil Pathophysiological Differences Between Postcapillary and Combined Pre- and Postcapillary Pulmonary Hypertension
Posted inCardiology news Respiratory

Distinct Lipid Metabolic Profiles Unveil Pathophysiological Differences Between Postcapillary and Combined Pre- and Postcapillary Pulmonary Hypertension

Posted by By MedXY 09/14/2026
This study reveals unique fatty acid and oxylipin metabolic signatures that differentiate isolated postcapillary pulmonary hypertension from combined pre- and postcapillary PH, highlighting potential biomarkers and therapeutic targets.
Read More
Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions
Posted inCardiology Clinical Updates news Pediatrics Respiratory

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions

Posted by By MedXY 09/13/2026
Rapid immunoassay-based classifiers accurately identify hyper- and hypoinflammatory subphenotypes in critically ill children, preserving prognostic and predictive utility and enabling precision therapies in acute pediatric cardiorespiratory failure.
Read More
Astegolimab for Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Insights from the Pooled ALIENTO and ARNASA Trials
Posted inClinical Updates news Respiratory

Astegolimab for Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Insights from the Pooled ALIENTO and ARNASA Trials

Posted by By MedXY 09/13/2026
Astegolimab, an anti-ST2 monoclonal antibody, significantly reduced moderate/severe exacerbations in COPD patients with frequent exacerbations in pooled ALIENTO and ARNASA analyses, showing promise for targeting the IL-33/ST2 pathway with good safety.
Read More
Tezepelumab Demonstrates Robust Efficacy and Safety Across Diverse Severe Asthma Phenotypes: Insights from the Phase 4 PASSAGE Study
Posted inAllergy & Immunology news Respiratory

Tezepelumab Demonstrates Robust Efficacy and Safety Across Diverse Severe Asthma Phenotypes: Insights from the Phase 4 PASSAGE Study

Posted by By MedXY 09/12/2026
The PASSAGE phase 4 study reveals tezepelumab significantly reduces exacerbation rates and improves lung function and quality of life in a broad US severe asthma population, including underrepresented groups and varied phenotypes.
Read More
Efficacy of Dupilumab in Reducing COPD Exacerbations, Emergency Department Visits, and Corticosteroid Use: Insights from a Pooled Phase 3 Analysis
Posted innews Respiratory

Efficacy of Dupilumab in Reducing COPD Exacerbations, Emergency Department Visits, and Corticosteroid Use: Insights from a Pooled Phase 3 Analysis

Posted by By MedXY 09/12/2026
Dupilumab significantly reduces emergency visits, hospital admissions, and systemic corticosteroid use in COPD patients with type 2 inflammation, offering a promising therapeutic option to mitigate exacerbation-associated morbidity.
Read More
Prevalence of Voice Fatigue and Its Correlation With Xerostomia in E-Cigarette Smokers
Posted innews Otorhinolaryngology Respiratory

Prevalence of Voice Fatigue and Its Correlation With Xerostomia in E-Cigarette Smokers

Posted by By MedXY 09/12/2026
This study explores the high prevalence of voice fatigue among e-cigarette users and its significant correlation with dry mouth (xerostomia).
Read More
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes: A Comprehensive Review
Posted inClinical Updates news Public Health Respiratory

Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes: A Comprehensive Review

Posted by By MedXY 09/10/2026
This review synthesizes emerging evidence demonstrating robust effectiveness of RSV vaccination in reducing hospitalization, death, and severe outcomes among elderly nursing home residents during the vaccine's inaugural season.
Read More
Enhancing COPD Detection through Integrated Quantitative CT Biomarkers in Lung Cancer Screening Programs
Posted innews Radiology Respiratory

Enhancing COPD Detection through Integrated Quantitative CT Biomarkers in Lung Cancer Screening Programs

Posted by By MedXY 09/10/2026
This study demonstrates that combining quantitative CT biomarkers with clinical data significantly improves the detection of previously undiagnosed COPD within lung cancer screening populations, optimizing referrals for confirmatory spirometry and enabling earlier diagnosis.
Read More
Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score
Posted inCardiology news Respiratory

Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score

Posted by By MedXY 09/10/2026
A newly developed clinical likelihood score accurately distinguishes pulmonary arterial hypertension patients with venous or capillary involvement (PVOD/PCH), enabling earlier diagnosis, tailored therapy, and timely transplant referral.
Read More
Expiratory Pressure Alleviation in CPAP Therapy: Impact on Upper Airway Patency and Obstructive Sleep Apnea Control
Posted innews Respiratory

Expiratory Pressure Alleviation in CPAP Therapy: Impact on Upper Airway Patency and Obstructive Sleep Apnea Control

Posted by By MedXY 09/09/2026
Expiratory pressure alleviation during CPAP treatment reduces upper airway patency, increases residual apnea severity, and necessitates higher therapeutic pressure in severe OSA patients, without affecting treatment adherence.
Read More
Optimizing Patient Expectations and Outcomes: Understanding Days Alive and Out of Hospital After Lung Transplantation
Posted innews Respiratory

Optimizing Patient Expectations and Outcomes: Understanding Days Alive and Out of Hospital After Lung Transplantation

Posted by By MedXY 09/09/2026
This study evaluates days alive and out of hospital (DAOH) around lung transplantation, identifying predictors of reduced DAOH in the first post-transplant year and providing insights for tailored patient counseling and care strategies.
Read More
Defining and Achieving Disease Stability in COPD: Insights from Phase 3 Trials
Posted innews Respiratory

Defining and Achieving Disease Stability in COPD: Insights from Phase 3 Trials

Posted by By MedXY 09/09/2026
This article explores disease stability as a key treatment target in COPD, analyzing major phase 3 trials that show stability predicts reduced exacerbations and mortality, supporting its use to guide therapy.
Read More
Reevaluating the Frequent Exacerbator Phenotype in Bronchiectasis: Insights from the EMBARC Registry
Posted innews Respiratory

Reevaluating the Frequent Exacerbator Phenotype in Bronchiectasis: Insights from the EMBARC Registry

Posted by By MedXY 09/09/2026
Analysis of over 19,000 bronchiectasis patients across 30 countries reveals a graded risk increase for future exacerbations with each prior event, challenging the fixed threshold concept of frequent exacerbators and confirming consistency across etiologies and regions.
Read More
Integrating Left Ventricular and Right Atrial Strain for Enhanced Prognostic Prediction in Pulmonary Arterial Hypertension
Posted inCardiology news Respiratory

Integrating Left Ventricular and Right Atrial Strain for Enhanced Prognostic Prediction in Pulmonary Arterial Hypertension

Posted by By MedXY 09/06/2026
Combining left ventricular global longitudinal strain and right atrial reservoir strain greatly improves risk prediction and stratification in pulmonary arterial hypertension, outperforming conventional imaging and clinical models.
Read More
Unveiling PUS7’s Role in Pulmonary Hypertension: A Novel Epigenetic Driver of Vascular Remodeling
Posted inCardiology news Respiratory

Unveiling PUS7’s Role in Pulmonary Hypertension: A Novel Epigenetic Driver of Vascular Remodeling

Posted by By MedXY 09/04/2026
This article explores how PUS7-induced pseudouridylation of TGFBI mRNA promotes pulmonary hypertension via epigenetic regulation, revealing promising new therapeutic targets.
Read More
Navigating Rehabilitation During ECMO Support: Insights from a Retrospective Cohort Study
Posted inCritical Care news Respiratory

Navigating Rehabilitation During ECMO Support: Insights from a Retrospective Cohort Study

Posted by By MedXY 09/04/2026
This study explores rehabilitation initiation, progression, and physical activity levels in adult ECMO patients, highlighting early active rehabilitation feasibility and varied activity trajectories based on clinical goals.
Read More
Serum Amyloid A as a Prognostic Biomarker in Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease
Posted inDermatology news Respiratory

Serum Amyloid A as a Prognostic Biomarker in Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease

Posted by By MedXY 09/03/2026
Elevated serum amyloid A correlates with rapidly progressive interstitial lung disease and mortality in dermatomyositis, with combined assessment alongside anti-MDA5 antibody improving risk stratification.
Read More

Posts pagination

Previous page 1 … 4 5 6 7 8 … 21 Next page

Take a game break

Explore a few games from MedXY.

Explore all games
  • Immersive Virtual Reality Enhances Naming Therapy in Chronic Post-Stroke Aphasia: A Randomized Controlled Trial
  • Metagenomic Insights into Salivary Microbiome Shifts During Periodontal Disease Progression
  • Comparative Effectiveness of Responsive Management Versus Renal Dialysis in Elderly UK Patients with Kidney Failure and Frailty: Insights from the Prepare for Kidney Care Trial and Related Advances
  • A U.S. Islamic Fatwa Supporting Pasteurized Donor Human Milk: How Clinicians Can Use Faith Guidance to Improve Neonatal Equity
  • Rising Global Impact and Economic Burden of Musculoskeletal Disorders Among Working-Age Adults (1990–2023)
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top